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Abstract. 
 
To examine the role of bone morphogenetic 
protein (BMP) signaling in chondrocytes during endo-
chondral ossification, the dominant negative (DN) 
forms of BMP receptors were introduced into imma-
ture and mature chondrocytes isolated from lower and 
upper portions of chick embryo sternum, respectively. 
We found that control sternal chondrocyte populations 
expressed type IA, IB, and II BMP receptors as well as 
BMP-4 and -7. Expression of a DN-type II BMP recep-
tor (termed DN-BMPR-II) in immature lower sternal 
(LS) chondrocytes led to a loss of differentiated func-
tions; compared with control cells, the DN-BMPR-
II–expressing LS chondrocytes proliferated more rap-
idly, acquired a fibroblastic morphology, showed little 
expression of type II collagen and aggrecan genes, and 
upregulated type I collagen gene expression. Expres-
sion of DN-BMPR-II in mature hypertrophic upper 
sternal (US) chondrocytes caused similar effects. In ad-
dition, the DN-BMPR-II–expressing US cells exhibited 
little alkaline phosphatase activity and type
 
 X 
 
collagen 
gene expression, while the control US cells produced 
both alkaline phosphatase and type
 
 X 
 
collagen. Both 
DN-BMPR-II–expressing US and LS chondrocytes 
failed to respond to treatment with BMP-2 . When we 
examined the effects of DN forms of types IA and IB 
BMP receptors, we found that DN-BMPR-IA had little 
effect, while DN-BMPR-IB had similar but weaker ef-
fects compared with those of DN-BMPR-II. We con-
clude that BMP signaling, particularly that mediated by 
the type II BMP receptor, is required for maintenance 
of the differentiated phenotype, control of cell prolifer-
ation, and expression of hypertrophic phenotype.
 
B
 
one
 
 morphogenetic proteins (BMPs)
 
1
 
 were origi-
nally identified as factors able to induce ectopic
 
endochondral ossification (Reddi,
 
 
 
1992). It has
been suggested that BMPs play a number of important
roles in skeletal formation. For example, in the developing
limb, BMPs appear to mediate the action of Sonic hedge-
hog during anterior–posterior axis determination (Francis
et al., 1994), to act as competitors for fibroblast growth
factors during proliferation of mesenchymal cells in the
progress zone (Niswander and Martin, 1993), and to be in-
ducers of programmed cell death in interdigital mesenchy-
mal cells (Yokouchi
 
 
 
et al., 1996; Zou and Niswander, 1996).
In addition, BMPs are possible regulators of proliferation
and differentiation of chondrocytes. BMP-2 and -4 are able
to induce differentiation of mesenchymal cells into chon-
drocytes (Chen
 
 
 
et al., 1991; Duprez
 
 
 
et al., 1996
 
a
 
), and
BMP-2, -3, and/or -4 stimulates and maintains proteogly-
can synthesis and enhances alkaline phosphatase (APase)
activity in differentiated chondrocytes in vitro (Hiraki
 
 
 
et al.,
1991; Luyten
 
 
 
et al., 1992, 1994). Although BMPs have var-
ious effects on chondrocytes, it remains unclear whether
and how they regulate the development and function of
chondrocytes at cellular level.
BMPs exert their biological function by interactions
with cell surface receptors. The BMP receptors consist of
heterodimers or heterotetramers of type I and type II re-
ceptors (Koenig
 
 
 
et al., 1994; Liu
 
 
 
et al., 1995; Nohno
 
 
 
et al.,
1995). Both types of receptors contain intracellular serine/
threonine kinase domains, which are required for signal-
 
Address all correspondence to Masahiro Iwamoto, Department of Oral
Anatomy and Developmental Biology, Osaka University Faculty of Den-
tistry, 1-8 Yamadaoka, Suita, Osaka 565, Japan. Tel.: 81-6-879-2872. Fax:
81-6-879-2875. E-mail: mal@dent.osaka-u.ac.jp
 
1. 
 
Abbreviations used in this paper
 
: APase, alkaline phosphatase; BMP,
bone morphogenetic protein; BMPR, BMP receptor; DN, dominant nega-
tive; GAG, glycosaminoglycan; RT-PCR, reverse transcriptase PCR; US
and LS, upper and lower sterna.
  
The Journal of Cell Biology, Volume 140, 1998 410
 
ing, and heteromeric complexes of two types of receptors
are necessary for high-affinity ligand binding and signaling
(Liu
 
 
 
et al., 1995; Nohno
 
 
 
et al., 1995). We recently cloned
chicken BMP receptors, i.e., BRK-1, -2, and -3, which cor-
respond to mammalian type IA, IB, and II receptors, re-
spectively (Kawakami
 
 
 
et al., 1996). To examine the role of
BMP signaling during chick limb chondrogenesis, we con-
structed viral vectors expressing dominant negative (DN)
forms of these receptors lacking the intracellular kinase
domain; these DN receptors are expressed at the cell sur-
face and bind BMPs, but they do not transmit signals (Ishi-
kawa
 
 
 
et al., 1995; Nohno
 
 
 
et al., 1995). We found that ex-
pression of a DN type IB receptor (termed DN-BMPR-IB)
caused suppression of chondrogenesis in vitro, and that co-
expression of DN type IB (DN-BMPR-IB) and type II
(DN-BMPR-II) receptors resulted in limb truncation, sug-
gesting that BMP signaling has crucial roles in chondro-
genesis and skeletal patterning in the developing limb
(Kawakami
 
 
 
et al., 1996).
In the present study, we used similar strategies to deter-
mine the role of BMPs in chondrocytes undergoing endo-
chondral ossification. During this process, immature small-
sized chondrocytes first proliferate rapidly, then withdraw
from mitotic activity and increase production of typical
cartilage matrix components such as type II collagen and
aggrecan, and finally mature into hypertrophic chondro-
cytes that produce abundant type
 
 X 
 
collagen and APase
(Horton, 1993). Accordingly, we isolated immature and
mature chondrocytes from the lower and upper portions
of chick embryo sternum (termed LS and US chondro-
cytes, respectively) (Leboy
 
 
 
et al., 1989; Iwamoto
 
 
 
et al.,
1993
 
a
 
). US chondrocytes mature to display terminal differ-
entiation phenotype characterized by synthesis of APase
and type
 
 
 
X collagen, and LS chondrocytes are immature
chondrocytes that do not proceed toward a terminal dif-
ferentiation stage. We found that introduction of DN-
BMPR-II into LS and US cells inhibited type II collagen
and aggrecan gene expressions, altered cell morphology,
and markedly changed the proliferative characteristics of
these cells. Furthermore, DN-BMPR-II severely inhibited
type
 
 X 
 
collagen gene expression and APase activity in US
cells. The results indicate that BMP signaling is required
for maintenance of the differentiated phenotype, control
of proliferation, and terminal differentiation in chondrocytes.
 
Materials and Methods
 
Cell Cultures
 
Chicken embryo fibroblasts were obtained from the torso of virus-free
White Leghorn 11-day-old embryos (line M) (Nisseiken, Yamanashi, Ja-
pan) and cultured in medium 199 containing 10% FBS. Upper sterna (US)
and lower sterna (LS) chondrocytes were isolated from the cephalic por-
tion and one-third caudal portion, respectively, of 17-day-old embryo (line
M) sternum and cultured in high-glucose DME containing 10% FBS as
described previously (Leboy
 
 
 
et al., 1989; Pacifici
 
 
 
et al., 1991). In serum-
free cultures, the cells were grown in DME containing 10
 
2
 
8
 
 M hydrocorti-
sone (Sigma Chemical Co., St. Louis, MO), 30 
 
m
 
g protein/ml egg yolk li-
poprotein (Cosmo Bio Co., LTD, Tokyo, Japan), 30 
 
m
 
g/ml transferrin
(Sigma Chemical Co.), 10 
 
m
 
g/ml insulin (Sigma Chemical Co.), 10
 
2
 
8
 
 M
thyroxine (Sigma Chemical Co.), and 10 
 
m
 
g/ml of ascorbic acid. The me-
dia were changed every other day. Recombinant human BMP-2 (rhBMP-
2) was provided from Yamanouchi Pharmaceutical Co. Ltd. (Tokyo, Ja-
pan) and was added starting on day 1 of culture.
 
Construction and Expression of Kinase
Domain–deficient BMP receptors (DN-BMPR-IA,
DN-BMPR-IB, and DN-BMPR-II)
 
Amino-terminal coding sequences of chicken type IA and type IB BMP
receptors, BMPR-IA and BMPR-IB, respectively (Kawakami
 
 
 
et al., 1996),
were subcloned into a modified pBluescript vector that contains a myc
epitope (MEQKLISEEDLN) and a stop codon. DN-BMPR-IA and -IB
clones contain amino-terminal 203 and 178 amino acids, respectively. DN-
BMPR-II construct was derived from the human type II BMP receptor
(Ishikawa
 
 
 
et al., 1995). To construct the truncated form of BMPR-II, a
myc epitope and a stop codon were inserted after Ile
 
540
 
 in the carboxyl
terminus by PCR. The DN-BMPR cDNAs were subcloned into the
RCAS(A) retroviral vector (Hughes
 
 
 
et al., 1987) and transfected into
chicken embryo fibroblasts by the calcium phosphate precipitation method
(Iwamoto
 
 
 
et al., 1993
 
b
 
). Recombinant virus in the medium was concen-
trated by centrifugation and used to infect freshly isolated US and LS
chondrocytes.
 
Northern Hybridization
 
Whole cellular RNAs isolated by the guanidium isothiocyanate method
(Smale and Sasse, 1992) were denatured by glyoxalation, electrophoresed
on agarose gels, transferred to Hybond-N membrane (Amersham Life
Science, Tokyo, Japan) by capillary blotting, and hybridized to 
 
32
 
P-labeled
DNA probes. Plasmids used were chick type
 
 X 
 
collagen cDNA pDLr10
(Leboy
 
 
 
et al., 1988), a 197-bp subclone of pYN3116 (Ninomiya
 
 
 
et al.,
1986); pCs2, a plasmid containing a 1.2-kb cDNA representing a portion
of the 3
 
9
 
 end of chicken 
 
a
 
1(II) collagen (Young
 
 
 
et al., 1984); pCPG.1, a
plasmid containing a 1.6-kb cDNA coding for a portion of the COOH-ter-
minal end of the chicken aggrecan (Oettinger and Pacifici, 1990); and
pCol3, a plasmid containing an 800-bp cDNA of the chicken
 
 
 
a
 
1(I) col-
lagen (Yamamoto
 
 
 
et al., 1980).
 
Reverse Transcriptase PCR for BMP-2, BMP-4, and 
BMP-7, and BMPR-IA, BMPR-IB, and BMPR-II
 
1 
 
m
 
g of whole cellular RNA was reverse transcribed by Superscript re-
verse transcriptase (GIBCO BRL, Gaithersburg, MD) and random hexam-
ers. Subsequent amplification was carried out with Elongase (GIBCO BRL)
and gene-specific primers for 30 cycles under the following conditions:
95
 
8
 
C for 10 s and 60
 
8
 
C for 1 min. Primers for amplification were as follows:
5
 
9
 
-CAG CTT CCA CCA CGA AGA AG-3
 
9
 
 and 5
 
9
 
-TAG GTT GTC
CGT GTG CAA TC-3
 
9
 
 for chick BMP-2 (Francis
 
 
 
et al., 1994), generating
a 341-bp fragment; 5
 
9
 
-CAC CAG GCA CAG ACT CAT CA-3
 
9
 
 and 5
 
9
 
-
AGG TAG AGC ATG GAG ATG GC-3
 
9
 
 for chick BMP-4 (Francis
 
 
 
et
al., 1994), generating a 425-bp fragment; 5
 
9
 
-ACC TTG GCC TGC AGC
TAT CT-3
 
9
 
 and 5
 
9
 
-CTC TGG AGC GAT GAT CCA GT-3
 
9
 
 for chick
BMP-7 (Houston
 
 
 
et al., 1994), generating a 332-bp fragment; 5
 
9
 
-AGC
GAT TGC TTG GAG CCT ATC T-3
 
9
 
 and 5
 
9
 
-AGC TGG CTT CTT CTG
TGG TGA A-3
 
9
 
 for chick BMPR-IA (Kawakami
 
 
 
et al., 1996); 5
 
9
 
-ATG
CTG CAC AGG CCA AGA TTA C-3
 
9
 
 and 5
 
9
 
-CCA AGA GCC TGT
GCC TTT AAT G-3
 
9
 
 for chick BMPR-IB (Kawakami
 
 
 
et al., 1996); and
5
 
9
 
-GGT CGA TAC GGA GCA GTG TAC A-3
 
9
 
 and 5
 
9
 
-CTG CTC CTT
CAA GCA CTT CTG G-3
 
9
 
 for chick BMPR-II (Kawakami
 
 
 
et al., 1996).
 
Measurement of DNA Content and Sulfated 
Glycosaminoglycan Content
 
Cultures were harvested in saline solution containing 0.2% Triton X-100
and 0.02
 
 
 
N
 
 
 
NaOH and sonicated. Cell lysates were centrifuged, and the
supernatant was used for determination of DNA and sulfated glycosami-
noglycan (GAG) contents by the fluorometric procedure of Johnson-Wint
and Wellis (1982) and direct spectrophotometric microassay of Frandale
et al. (1982), respectively.
 
Measurement of APase Activity
 
APase activity associated with the cell layer was measured by a modifica-
tion of Bessey et al. (1946) using 
 
p
 
-nitrophenyl phosphate as a substrate as
described previously (Pacifici
 
 
 
et al., 1991).
 
Histochemistry
 
Cultures were washed with PBS twice, fixed with 3.7% neutralized form- 
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aldehyde solution, and stained with 0.5% crystal violet in 20% methanol
(Zhang
 
 
 
et al., 1993). To detect cartilage matrix accumulation, cultures
were fixed with 3% acetic acid (adjusted to pH 1.0 with HCl) for 5 min
and stained with 0.1% Alcian blue in 3% acetic acid, pH 1.0 (Lev and
Spicer, 1964). To detect APase activity, cultures were washed with saline
twice, incubated with 50 mM Tris-HCl, pH 9.5, containing 0.5 mg/ml of
naphthol AS-BI phosphate and 1 mg/ml of Fast Red trisodium salts
(Sigma Chemical Co.) for 15 min at 37
 
8
 
C (Leboy
 
 
 
et al., 1989), and then
fixed with 3.7% neutralized formaldehyde solution. 
For determination of efficiency of virus infection, cultures were har-
vested by trypsinization and replated on poly-
 
l
 
-lysine–coated dishes at the
density of 2.0
 
 3 
 
10
 
6
 
 cells/ml. After 15 min, cultures were washed with PBS
twice, fixed with 3.7% neutralized formaldehyde solution, and permeabi-
lized by incubation with PBS containing 0.5% Triton X-100 for 15 min.
Cultures were then incubated with hybridoma supernatant containing
AMV-3C2 (Developmental Studies Hybridoma Bank, Baltimore, MD), a
mouse monoclonal antibody against the 
 
gag
 
 protein of avian myeloblasto-
sis virus, recognizing cells harboring Rous sarcoma or avian leukemia
virus. For determination of expression of the constructed genes, parallel
cultures were incubated with ascites fluid containing 9E10 (Berkeley An-
tibody Company, Richmond, CA), a mouse monoclonal antibody that rec-
ognizes the amino acid sequence EQKLISEEDL, a specific portion of the
human 
 
c-myc
 
 gene. Localization of the antibody was visualized by ABC
methods using Histofine kits (Nichirei, Tokyo, Japan). 
 
Results
 
Expression of BMP Receptors and BMPs
in Chondrocytes
 
In the first series of experiments, we examined whether
chick sternal chondrocytes express BMP receptors and
BMPs. Total RNAs were extracted from sterna of 17-day-
old chicken embryos and subjected to reverse transcrip-
tase PCR (RT-PCR) (Fig. 1 
 
A
 
). After 30 cycles of RT-PCR
amplification, BMPR-IA, -IB, and -II were detectable
(Fig. 1 
 
A
 
). A similar 30-cycle amplification revealed that
the sternal cartilage contained transcripts encoding BMP-4
and -7, whereas only trace amounts of BMP-2 transcripts
were visible after 40 cycles. When RNAs were isolated
from cultured chondrocytes and examined by RT-PCR,
similar results were obtained (Fig. 1 
 
B
 
). These findings in-
dicate that chondrocytes expressed BMPR-IA, BMPR-IB,
BMPR-II, BMP-4, and BMP-7, while BMP-2 expression
was undetectable.
 
Infection of Chondrocytes with Viral Particles 
Encoding DN-BMPR-IA, BMPR-IB, and BMPR-II
 
Before analyzing the phenotypic effects of DN-BMPRs on
chondrocytes, it was important to establish that most cells
became rapidly infected by the recombinant viral particles
and expressed the recombinant protein. Accordingly, pri-
mary populations of immature and mature chondrocytes
isolated from the LS and US portions of day 17 chick em-
bryo sternum, respectively, were infected with viruses en-
coding DN-BMPR-IA, -IB or -II and harvested by tryp-
sinization 1 wk after infection. Efficiency of viral infection
was determined by immunohistochemical analysis using
an antibody against viral 
 
gag protein. We found that more
than 95% of both US and LS chondrocytes had become in-
fected (Figs. 2, H–J, and 3 D); a similar efficiency was dis-
played by control viruses (Figs. 2 G and 3 B). Uninfected
cultures were negative (Fig. 2 F). 
To determine whether the infected cultures produced
recombinant protein, cultures were stained with an anti-
body to the c-myc tag (Fig. 2, K–O). Cells infected with vi-
ruses encoding DN-BMPR-IA (Fig. 2 M), DN-BMPR-IB
(Fig. 2 N), or BMPR-II (Fig. 2 O) were nearly all positive,
while uninfected cells (not shown) and control-virus in-
fected cells (Fig. 2 L) were weakly positive, and their posi-
tive signal was limited to the nucleus, probably reflecting
endogenous c-myc. 
The data show that chondrocytes are rapidly infected by
the recombinant viruses used and readily express virally
encoded recombinant protein. 
Morphological Changes Induced by Expression
of DN-BMPRs
Primary uninfected and infected US cultures described
above were subcultured and grown for an additional 6 d in
secondary cultures. In the uninfected cultures (Fig. 2 A)
and the cultures infected with the control virus (Fig. 2 B),
the US chondrocytes displayed hypertrophic phenotype;
the cells were large in size, polygonal to round in shape,
and surrounded by a refractile matrix, and their growth rates
were very slow. The cultures infected with DN-BMPR-IA
virus (Fig. 2 C) were morphologically indistinguishable
from the control cultures. In contrast, the cultures infected
with DN-BMPR-IB virus contained fibroblastic-shaped
cells, and the growth rate of these cultures was higher than
that of the controls (Fig. 2 D). The effect of DN-BMPR-
II–encoding virus was more remarkable; all of the cells in
these cultures became fibroblastic (Fig. 2 E), actively pro-
liferated, and reached confluency in 5 d. Similar effects
were obtained with LS cultures. The control immature LS
chondrocytes and control virus–infected chondrocytes ex-
hibited the expected smaller size and a polygonal mor-
phology (Fig. 3 A), while the DN-BMPR-II–expressing
(Fig. 3 C) or DN-BMPR-IB–expressing (not shown) LS
Figure 1. Expression of BMP receptors and BMPs in chondro-
cytes. Total RNA was isolated from (A) day 17 chicken embryo
sterna and (B) upper sternal chondrocytes cultured for 3 d. RT-
PCR for the indicated gene was performed as described in Mate-
rials and Methods. Amplified products were analyzed by 2% aga-
rose gel electrophoresis.The Journal of Cell Biology, Volume 140, 1998 412
chondrocytes displayed a fibroblastic shape and high prolif-
erative activity (Fig. 3 C). As seen in US cultures, the ef-
fects of DN-BMPR-IA were weak in LS cultures.
To determine whether expression of DN-BMPRs
blocked the ability of chondrocytes to respond to BMPs,
the above US and LS cultures were treated with 200 ng/ml
of rhBMP-2. Uninfected cells and the cells infected with
control viruses readily responded to this BMP-2 treat-
ment, as indicated by a change from a polygonal to round
cell morphology and increased pericellular refractile ma-
trix (Fig. 4, B and F) compared with their respective un-
treated controls (Fig. 4, A and E). In contrast, DN-BMPR-
II–expressing cells did not appear to respond to BMP-2
treatment (Fig. 4, D and H) and closely resembled their
untreated counterparts (Fig. 4, C and G). 
Stimulation of Cell Proliferation by DN-BMPRs
To obtain quantitative data on the effects of DN-BMPRs
on proliferation of chondrocytes, a DNA content analysis
was performed. In secondary cultures of US chondrocytes,
most of the control cells (RCAS) and DN-BMPR-IA–express-
ing cells became postmitotic, while DN-BMPR-II– or
DN-BMPR-IB–expressing cells exhibited strong prolifera-
tive activity and accumulated about 5.0- and 2.5-fold more
DNA than controls on day 6. 
Figure 2. Efficiency of infec-
tion in upper sternal chon-
drocyte cultures by DN-
BMPR–encoding viruses.
Freshly isolated US chondro-
cytes were infected with
RCAS viruses encoding DN-
BMPR-IA (C, H, and M),
DN-BMPR-IB (D, I, and N),
DN-BMPR-II (E, J, and O),
or vector alone (B, G, K, and
L) for 3 d in medium 199
containing 10% FBS. The
medium was then changed
to high glucose DME con-
taining 10% FBS, and cells
were cultured for an addi-
tional 4 d. On day 7, the cells
were harvested and replated
in 35-mm dishes at the den-
sity of 1.5 3 105 cells/dish,
and the microscopic photo-
graphs of live cells were
taken after 5 d (A–E). Ali-
quots of the harvested cells
were plated onto poly-
l-lysine–coated dishes at the
density of 2.0 3 106/ml, fixed
with 3.7% formaldehyde af-
ter 15 min from plating, and
stained with antibodies to the
RCAS virus gag protein
(F–J) or c-myc peptide (L–O)
as described in Materials and
Methods. A and F represent
uninfected cultures. K is a
culture incubated with con-
trol nonimmune ascites.Enomoto-Iwamoto et al. Role of BMP Signaling in Chondrocytes 413
In LS chondrocyte cultures, the control cells (RCAS) ac-
tively proliferated. DN-BMPR-II–expressing LS cultures
proliferated even more rapidly, and the DNA content was
twofold compared with the control value (Fig. 5 B). 
Changes in Proteoglycan and Collagen Expression 
Produced by DN-BMPRs
We next investigated the effects of DN-BMPRs on pro-
teoglycan synthesis and accumulation, as measured by bio-
chemical quantification of sulfated GAG content and histo-
chemical staining. Proteoglycan synthesis and accumulation
were severely inhibited by DN-BMPR-II, moderately by
DN-BMPR-IB, and weakly by DN-BMPR-IA (Figs. 6 A
and 7). The uninfected cultures and the control cultures in-
fected with RCAS virus carrying vector alone responded
to exogenous rhBMP-2, and their GAG synthesis was en-
hanced 1.5- to 2.0-fold by the addition of the protein, as
reported before (Hiraki et al., 1991). In contrast, DN-
BMPR-II–expressing cultures did not show an enhance-
ment of GAG synthesis in response to BMP-2 treatment,
and DN-BMPR-IA–expressing cultures and DN-BMPR-
IB–expressing cultures showed weaker responses to BMP-2
(Figs. 6 A and 7). Similar results were obtained in cultures
of immature LS chondrocytes (Fig. 6 B).
The inhibitory effects of DN-BMPR-IB and -II on pro-
teoglycan synthesis were also detectable by Northern blot
analysis. As shown in Fig. 8, the expression of the aggre-
can gene (PG) was decreased by DN-BMPR-IB and -II in
both LS and US cultures, and the expression of the type II
collagen gene (II) was also inhibited by these mutants in
both US and LS cultures. In contrast, an induction of type
I collagen gene expression (I) was observed in both DN-
BMPR–expressing LS and US cultures (Fig. 8). 
It may be argued that the above downregulation of type
II collagen and aggrecan gene expression and the concom-
itant increase in type I collagen gene expression do not
reflect specific effects of DN-BMPRs on the phenotype of
differentiated chondrocytes but are rather parts of an
overall generalized process of dedifferentiation, in which
the cells become morphologically and biochemically fibro-
blast-like cells. To address this point, we investigated
whether the DN-BMPR–expressing chondrocytes would
reexpress their differentiated phenotype once they were
switched from monolayer to suspension. The rationale be-
hind this experiment is that dedifferentiated chondrocytes
in monolayer have been shown to reexpress differentiated
traits when they were switched to suspension culture (Benya
and Shaffer, 1982). Accordingly, control virus–infected
and DN-BMPR-II–expressing LS cultures were switched
from monolayer to suspension culture, and DNA and pro-
teoglycan contents were measured 7 d later. We found that
Figure 3. Efficiency of infection in lower sternal chondrocyte cul-
tures by DN-BMPR-II–encoding virus. Freshly isolated LS chon-
drocytes were infected with RCAS virus encoding DN-BMPR-II
(C and D) or vector alone (A and B) in medium 199 containing
10% FBS for 3 d and were then processed as cells in Fig. 2. (A)
Control cells; (B) control cells stained with viral gag antibody;
(C) BMPR-II–expressing cells; (D) BMPR-II–expressing cells
stained with viral gag antibody. 
Figure 4. Effects of the exogenous BMP-2 on the cell morphol-
ogy. Freshly isolated US (A–D) and LS (E–H) chondrocytes
were infected with RCAS virus encoding DN-BMPR-II (C, D, G,
and H) or vector alone (A, B, E, and F) in medium 199 containing
10% FBS for 3 d. The medium was then changed to high glucose
DME containing 10% FBS. On day 7 (US) or 5 (LS), the cells
were harvested and replated in 35-mm dishes at the density of 1.5 3
105 cells/dish. 200 ng/ml of rhBMP-2 was added on the next day
(B, D, F, and H). Photographs was taken after 5 d.The Journal of Cell Biology, Volume 140, 1998 414
the DNA content was the same in both cultures, suggest-
ing that the stimulation of proliferation by DN-BMPR-II
is anchorage dependent. However, the proteoglycan con-
tent of DN-BMPR-II–expressing cultures was z30% of
that of the control cultures, indicating that DN-BMPR-II
inhibited proteoglycan synthesis even in suspension cul-
tures and that the cells had not reacquired the ability to
express differentiated functions in suspension. 
Inhibition of Terminal Differentiation by DN-BMPRs
Having shown that DN-BMPRs can inhibit expression of
chondrocyte-characteristic products, we next examined
whether they can also inhibit expression of products typi-
cal of mature hypertrophic US chondrocytes, such as type
X collagen and APase. Northern blot analyses revealed
that DN-BMPR-II completely inhibited expression of type
X collagen (Fig. 8) and APase activity (Fig. 7) compared
with control cultures. DN-BMPR-IB had similar but more
moderate effects, while DN-BMPR-IA had marginal ef-
fects (Figs. 7 and 8). 
Treatment with rhBMP-2 caused a marked stimulation
of APase activity in control cultures (Fig. 7). In contrast,
rhBMP-2 elicited a small response in cultures expressing
DN-BMPR-IA or -IB and no response in cultures express-
ing DN-BMPR-II (Fig. 7).
Effects of DN-BMPRs in Serum-free Cultures
In a final set of experiments, we asked whether the effects
caused by expression of DN-BMPRs in chondrocytes were
affected by or dependent on the serum present in the cul-
ture medium. Thus, primary US cultures expressing DN-
BMPR-II were replated and maintained in serum-free me-
dium for 7 d. As shown in Fig. 9, in this chemically defined
medium the DN-BMPR-II–expressing cells contained over
twofold more DNA than control cultures, as seen in stan-
dard serum-containing cultures described above. Likewise,
APase activity and proteoglycan content were significantly
lower in DN-BMPR-II cultures than in the control cultures
(Fig. 9). The effects of DN-BMPR-IB were weaker than
those of DN-BMPR-II, and the effects of DN-BMPR-IA
were marginal. DN-BMPRs thus inhibited expression of
differentiated functions in chondrocytes in both serum-
free and serum-containing cultures. 
Discussion
Roles of BMP Signaling during
Chondrocyte Maturation
The results of our study show that an interference with
BMP signaling by expression of DN-BMPR-II or -IB in
both immature and mature chondrocytes alters the prolif-
erative characteristics of the cells and inhibits expression
Figure 5. Effects of DN-BMPRs on cell proliferation. US (A)
and LS (B) chondrocytes were infected with DN-BMPR viruses,
harvested by trypsinization on day 7 and 5, respectively, and then
replated in 35-mm dishes at the density of 1.5 3 105 cells/dish.
DNA contents were determined at the indicated times as de-
scribed in Materials and Methods. Values represent average 6
SD for three cultures, and similar results were obtained in three
independent experiments.
Figure 6. Effects of DN-BMPRs on GAG synthesis in US and LS
chondrocyte cultures. US (A) and LS (B) chondrocytes were in-
fected with DN-BMPR viruses, harvested by trypsinization on
day 7 (US) or day 5 (LS), and then replated in 24-well plates at
the density of 5.0 3 104 cells/dish. Sulfated GAG and DNA con-
tents were determined on day 5 as described in Materials and
Methods. rhBMP-2 was added from day 1 at the concentration of
200 ng/ml. Data represent average 6 SD for three cultures, and
similar results were obtained in two independent experiments.Enomoto-Iwamoto et al. Role of BMP Signaling in Chondrocytes 415
of differentiated and maturation-related traits, including
types II and X collagen, aggrecan, and APase. At the same
time, the cells acquire a fibroblastic morphology and up-
regulate expression of type I collagen. These phenotypic
alterations do not simply reflect a generalized dedifferen-
tiation process in chondrocytes caused by the DN-BMPRs.
When DN-BMPR-II–expressing cells were shifted from
monolayer to suspension, they were not able to restore
normal proteoglycan production, even though a similar
shift has been shown to restore function in chondrocytes
dedifferentiated by protracted growth in monolayer (Benya
and Shaffer, 1982). In addition, the downregulation of type
II collagen gene expression and the upregulation of type I
collagen gene expression were more severe in DN-BMPR-
II–expressing LS than in the US chondrocytes, indicating
that the effects of DN-BMPR-II are not generalized but
are the results of specific interactions with the ongoing
maturation programs of LS and US chondrocytes. It is sug-
gested then that BMP signaling has a crucial role at multi-
ple steps during chondrocyte development in endochon-
dral bone formation and is essential for maintenance of
the differentiated chondrocyte phenotype, modulation of
proliferative activity normally occurring during chondro-
cyte maturation, and expression of terminal mature func-
tions by hypertrophic chondrocytes. Each step of the mat-
uration process is important for normal skeletogenesis,
and disturbances result in skeletal deformities (Horton
and Hecht, 1993); it follows that any alteration of BMP
signaling may lead to destabilization of the chondrocyte
maturation process and may affect skeletogenesis at any
given step. Our results and conclusions correlate well with
and extend our previous studies on the roles of BMP sig-
naling during differentiation of mesenchymal cells into chon-
drocytes (Kawakami et al., 1996). Interestingly, we found
that DN-BMPR-IB inhibited mesenchymal cell differenti-
ation, whereas DN-BMPR-II had little effect. Thus, the
type IB BMP receptor may interact with other receptors
such as the activin type II receptor (Stern et al., 1995; Ya-
mashita et al., 1995) and affect mesenchymal cell differen-
Figure 7. Histochemical analysis of proteoglycan accumulation
and APase activity in US chondrocytes infected by DN-BMPR
viruses. US chondrocytes were infected with RCAS virus encod-
ing DN-BMPRs or vector alone (RCAS) and replated on type I
collagen–coated 96-well plates at the density of 2.0 3 104 cells/
dish on day 7. Cells were cultured in the presence of 10 mg/ml of
ascorbic acid with (BMP (1)) or without (BMP (2)) rhBMP-2
(200 ng/ml) for 7 d. Cultures were then fixed with 3.7% formalde-
hyde and stained with Alcian blue (lanes 1 and 4) or crystal violet
(lanes 3 and 6) as described in Materials and Methods. Lanes 2
and 5 show the results of histochemical detection of APase. 
Figure 8. Changes in expression of extracellular matrix genes in-
duced by DN-BMPRs. LS (lanes 1–5) and US (lanes 6–10) chon-
drocytes were infected with RCAS virus encoding DN-BMPR-IA
(lanes  3 and 8), DN-BMPR-IB (lanes 4 and 9), DN-BMPR-II
(lanes 5 and 10), or vector alone (lanes 2 and 7), harvested by
trypsinization on day 7 for US and day 5 for LS, and then re-
plated in 100-mm dishes at the density of 1.0 3 106 cells/plate. 7 d
after plating, whole cellular RNAs were extracted, separated on
agarose gels, and blotted onto nylon membranes. Membranes
were hybridized to 32P-labeled probes encoding type I collagen
(I) and type X collagen (X) and then reblotted with the 32P-labeled
probes encoding type II collagen (II ) and aggrecan (PG), respec-
tively. Blots were prestained with methylene blue to mark the
28S and 18S rRNA subunits. Lanes 1 and 6 represent uninfected
cultures.The Journal of Cell Biology, Volume 140, 1998 416
tiation, while the type II BMP receptor may be more criti-
cal in differentiated chondrocytes undergoing maturation
and endochondral ossification. 
 The withdrawal from mitotic activity is an essential step
in the normal progression of terminal differentiation of
chondrocytes during endochondral bone formation (Kato
et al., 1988). We showed previously that when immature
chondrocytes are forced to remain proliferative, for exam-
ple by overexpression of c-myc, they are unable to mature
into hypertrophic chondrocytes (Iwamoto et al., 1993).
Our present data show that interference with BMP signal-
ing also forces immature LS chondrocytes into a more ac-
tive proliferative behavior and reinitiates mitotic activity
in mature US chondrocytes. We have recently observed
that overexpression of BMP-2 or -4 in cultured sternal
chondrocytes leads to a decrease in proliferative activity as
well (our unpublished observations). Thus, BMP signaling
appears to be an important part of mechanisms by which
proliferation is tightly regulated during chondrocyte matu-
ration. We should acknowledge here seemingly contrasting
data reported by others, in which treatment with BMP-2, -3
or -4 was found to cause increases in thymidine incorpora-
tion into cultured chondrocytes (Hiraki et al., 1991; Luyten
et al., 1994). Because the stimulatory effect is not strong as
compared with other mitogens, and since there are no re-
ports that BMPs increase cell number, the stimulation of
thymidine incorporation by BMPs might not be directly
linked to cell division.
Ligands and Receptors as Components of BMP 
Signaling in Chondrocytes
Our RT-PCR data show that chondrocytes contain tran-
scripts encoding type IA, IB, and II BMP receptors. In the
developing limb, the type IB and II receptors are ex-
pressed in precartilaginous regions, while the type IA re-
ceptor is expressed at lower levels and more broadly (De-
wulf et al., 1995; Kawakami et al., 1996). The expression
of type IA receptor is upregulated specifically in prehyper-
trophic chondrocytes (Zou et al., 1997). In the present
study, the DN-BMPR-II and -IB were strong and moder-
ate suppressors, respectively, of phenotypic expression in
chondrocytes, while DN-BMPR-IA showed only weak ef-
fects. Based on the identical expression of the c-myc tag
attached to each of the DN-BMPRs that we observed, it
appears that the different effectiveness of the DN-BMPRs
in phenotypic inhibition is not due simply to differences in
expression levels; the c-myc tag was equally evident after
expression of every DN form in chondrocytes. Rather, it
appears that the BMP receptors most functionally relevant
in chondrocytes are the type IB and type II BMP recep-
tors. Zou et al. (1997) have reported that expression of a
constitutively activated form of type IA BMP receptor in
developing limb delays maturation of cartilage, whereas
the same form of type IB receptor does not. Their findings
and our results may be two sides of one coin. The expres-
sion of the dominant negative form of type IB receptor
may not only interrupt the BMP signaling through type IB
receptor but may also activate the signaling pathway
through the other type I receptor, type IA receptor. Con-
versely, activation of type IA receptor may inactivate the
BMP signaling through type IB receptor. However, fur-
ther investigation should be required before any conclu-
sions are made as to how and which type I BMP receptor
regulates chondrocyte function. 
A number of BMPs have been shown to be expressed in
prechondrogenic cells and chondrocytes. For example,
BMP-2 and -4 transcripts are present in the limb interdigi-
tal zones and the mesenchyme surrounding the chondro-
genic regions (Francis et al., 1994). BMP-7 proteins are
detected in hypertrophic chondrocytes of vertebrae of hu-
man embryos by immunohistochemical methods (Vuki-
cevic  et al., 1994), and BMP-6 transcripts are detectable in
freshly isolated growth plate chondrocytes (Carey and Liu,
1995). Growth and differentiation factor 5 (GDF5), a mem-
ber of the BMP superfamily that binds to BMPR-IB and -II
and activin receptor-II and -IIB, is expressed in cartilage
(Nishitoh et al., 1996). Our data show that transcripts en-
coding BMP-4 and -7 are present in sternal chondrocytes.
It is possible that BMP-4, BMP-7, or heterodimers of these
BMPs are components of BMP signaling operating in
chondrocytes undergoing endochondral ossification. These
BMPs may be important endogenously produced regula-
tors of chondrocyte activity, given our observation that in
serum-free cultures, interference with BMP signaling path-
way led to inhibition of proteoglycan synthesis and APase
activity. However, since we observed higher APase activ-
ity in serum-containing versus serum-free cultures, it is also
possible that serum components, including serum-derived
BMPs, may have a favorable effect on phenotypic expres-
Figure 9. Effects of DN-
BMPRs on US chondrocytes
in serum-free cultures. US
chondrocytes were infected
with RCAS virus encoding
DN-BMPRs or vector alone
(RCAS) and replated in type
I collagen–coated 96-well
plates at the density of 1.0 3
104 cells/dish on day 7. Cells
were then cultured in chemi-
cally defined medium as de-
scribed in Materials and
Methods for 7 d. The DNA content (A), sulfated GAG content (B), and APase activity (C) were measured as described in Materials
and Methods. The data represent average 6 SD for three cultures. * unit: One unit of APase activity corresponds to the hydrolysis of 1
nmol per min.Enomoto-Iwamoto et al. Role of BMP Signaling in Chondrocytes 417
sion in chondrocytes. In summary, combinations of auto-
crine and paracrine BMP signaling mechanisms are likely
to be operative in chondrocytes undergoing endochondral
ossification.
The involvement of BMPs in chondrocyte metabolism
and function was previously suggested by the findings that
BMP treatment stimulates proteoglycan synthesis and APase
activity and inhibits proteoglycan degradation in cultured
chondrocytes (Hiraki et al., 1991; Luyten et al., 1992, 1994;
Erickson et al., 1997). Likewise, ectopic expression of
BMP-2, -4, or -7 was shown to cause increased cartilage
growth and deformities in vivo (Duprez et al., 1996b;
Monsoro-Burq et al., 1996). However, these studies did
not provide information on the essential role of BMP sig-
naling in chondrocytes. BMP or BMPR gene knockout
studies, which could potentially provide such information,
resulted in embryonic lethality at very early stages (Mish-
ina et al., 1995; Zhang and Bradley, 1996) and thus could
not provide information on the roles of BMPs in skeletal
development. In conclusion, our study of the effects of
BMP signaling interference provides the first clear demon-
stration that BMP signaling is essential in chondrocytes
and exerts key functions in the regulation of endochondral
bone formation, including maintenance of the differenti-
ated chondrocyte phenotype, control of proliferative activ-
ity, and expression of the mature hypertrophic phenotype. 
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